Loading...
XJPX
4540
Market cap1.83bUSD
Dec 05, Last price  
3,822.00JPY
1D
-0.73%
1Q
1.59%
Jan 2017
18.70%
Name

Tsumura & Co

Chart & Performance

D1W1MN
XJPX:4540 chart
P/E
8.76
P/S
1.57
EPS
436.23
Div Yield, %
3.09%
Shrs. gr., 5y
-0.15%
Rev. gr., 5y
8.00%
Revenues
181.09b
+20.05%
90,425,000,00091,252,000,00094,804,000,00090,027,000,00090,933,000,00094,778,000,00095,451,000,000105,639,000,000110,057,000,000110,438,000,000112,618,000,000114,957,000,000117,882,000,000120,906,000,000123,248,000,000130,881,000,000129,546,000,000140,043,000,000150,845,000,000181,093,000,000
Net income
32.43b
+94.10%
12,380,000,00013,152,000,0009,139,000,00010,777,000,00010,704,000,00012,945,000,00013,431,000,00015,373,000,00018,050,000,00014,075,000,00012,557,000,00012,488,000,00014,504,000,00014,593,000,00013,765,000,00015,332,000,00018,836,000,00016,482,000,00016,707,000,00032,428,000,000
CFO
33.82b
+503.12%
14,593,000,00012,687,000,0005,358,000,00010,634,000,00012,019,000,00012,047,000,0007,314,000,00012,011,000,0005,908,000,0004,992,000,00017,570,000,00021,065,000,00021,066,000,0005,450,000,00018,191,000,00016,102,000,00021,314,000,00016,452,000,0005,608,000,00033,823,000,000
Dividend
Mar 30, 202676 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Tsumura & Co. engages in the manufacture and sale of pharmaceutical products worldwide. The company offers Kampo extract intermediates and granular Kampo formulations. It is involved in the procurement, selection and processing, and storage of raw material crude drugs and crude drug pieces for decoction; manufacture of Kampo powdered extracts and traditional Chinese medicines; and sale of pharmaceuticals and food products. The company was founded in 1893 and is headquartered in Tokyo, Japan.
URL
https://www.tsumura.co.jp/
IPO date
Nov 21, 1980
Employees
4,032
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT